BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A

BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A

Shots:

  • BrightInsight’s CE-marked dosing calculator enables health care professionals to determine the correct dosage & number of vials based on recommended dosage for the treatment of Hemophilia A with its development & distribution sponsored by Roche
  • The calculator helps in determining the correct loading and maintenance dose of emicizumab based on BrightInsight’s Internet of Things platform providing digital health solutions
  • The dosing Calculator is built under its ISO 13485:2016 Certified QMS and is a CE marked SaMD, used by healthcare professionals in Europe

Click here to read full press release/ article | Ref: Business Wire | Image: Chicago Tribune